BIG1 — Bio-Gate AG Share Price
0.000.00%
Last trade - 00:00- €7.76m
- €7.35m
- €7.25m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.39 | ||
| Price to Tang. Book | 6.57 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.03 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -58.14% | ||
| Return on Equity | -69.75% | ||
| Operating Margin | -26.11% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 3.49 | 5.13 | 6.24 | 5.99 | 7.25 | n/a | n/a | 14.45% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Bio-Gate AG is a Germany-based medical technology company. The Company employs silver technology to endow materials and products with antimicrobial properties, and specializes in plasmacoating, spray, additives and textile solutions, among others. It produces medical technology products, as well as technologies to refine cosmetics, consumer goods and industrial products. Its products are applied in the area of implants, skin care, cosmetics, orthopedics, industrial applications, consumer goods, would care, textiles and dental products. The Company incorporates silver particles into cosmetics, paints, veneers or plastics, or involves coating of final products, such as implants or wound dressings, with a silver-containing functional layer.
Directors
- Karl Richter CSU
- Marc Lloret-Grau CMG
- Volker Rofalski VSU (51)
- Amir Al-Munajjed CTO
- Thomas Konradt MGB (45)
- Volker Alt SUB
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- December 16th, 2005
- Public Since
- April 5th, 2006
- No. of Employees
- 45
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- XETRA
- Shares in Issue
- 9,243,691
- Address
- Neumeyerstrasse 28-34, NUERNBERG, 90411
- Web
- https://www.bio-gate.de/
- Phone
- +49 911477523100
- Contact
- Gerd Rueckel
- Auditors
- Rodl & Partner GmbH
Upcoming Events for BIG1
Half Year 2025 Bio-Gate AG Earnings Release
Similar to BIG1
Aap Implantate AG
XETRA
elexxion AG
XETRA
FAQ
What is the Bio-Gate AG share price?
As of Today at 19:35 UTC, shares in Bio-Gate AG are trading at €0.84. This share price information is delayed by 15 minutes.
How has the Bio-Gate AG share price performed this year?
Shares in Bio-Gate AG last closed at €0.84 and the price had moved by -16% over the past 365 days. In terms of relative price strength the Bio-Gate AG share price has underperformed the FTSE Global All Cap Index by -18.1% over the past year.
What are the analyst and broker recommendations for Bio-Gate AG?
There is no consensus recommendation for this security.
Find out moreWhat is the Bio-Gate AG dividend yield?
Bio-Gate AG does not currently pay a dividend.
Does Bio-Gate AG pay a dividend?
Bio-Gate AG does not currently pay a dividend.
When does Bio-Gate AG next pay dividends?
Bio-Gate AG does not currently pay a dividend.
How do I buy Bio-Gate AG shares?
To buy shares in Bio-Gate AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Bio-Gate AG?
As of the previous close price of €0.84, shares in Bio-Gate AG had a market capitalisation of €7.76m.
Where are Bio-Gate AG shares listed?
Here are the trading details for Bio-Gate AG:
- Country of listing: Germany
- Exchange: GER
- Ticker Symbol: BIG1
What kind of share is Bio-Gate AG?
Based on an overall assessment of its quality, value and momentum Bio-Gate AG is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Bio-Gate AG share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Bio-Gate AG share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bio-Gate AG. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +7.55%.
As of the last closing price of €0.84, shares in Bio-Gate AG were trading +4.03% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Bio-Gate AG PE Ratio?
The Bio-Gate AG PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €0.84.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Bio-Gate AG?
Bio-Gate AG's management team is headed by:
- Karl Richter - CSU
- Marc Lloret-Grau - CMG
- Volker Rofalski - VSU
- Amir Al-Munajjed - CTO
- Thomas Konradt - MGB
- Volker Alt - SUB